Evofem Biosciences, Inc.·4

Feb 23, 4:06 PM ET

File Justin J. 4

4 · Evofem Biosciences, Inc. · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-18
File Justin J.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-02-18+450,000810,982 total
  • Award

    Stock option (right to buy)

    2022-02-18+450,000450,000 total
    Exercise: $0.49Exp: 2032-02-18Common Stock (450,000 underlying)
Footnotes (2)
  • [F1]The restricted stock awards will vest based on the Issuer's achievement of certain performance milestones in 2022.
  • [F2]The shares of common stock exercisable pursuant to the option will vest in a series of forty-eight (48) successive equal monthly installments upon completion of each additional month of service for the Issuer measured from February 18, 2022.

Documents

1 file
  • 4
    wf-form4_164565040087112.xmlPrimary

    FORM 4